# Factors Associated With End Stage Liver Disease

> **NCT01846819** · — · TERMINATED · sponsor: **NYU Langone Health** · enrollment: 27 (actual)

## Conditions studied

- Cirrhosis
- Hepatic Encephalopathy
- Fatigue
- Depression

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01846819
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07
- **Primary completion:** 2014-05
- **Final completion:** 2014-12
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2017-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01846819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01846819, "Factors Associated With End Stage Liver Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01846819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
